Application of SPECT and PET / CT with computer-aided diagnosis in bone metastasis of prostate cancer: a review

Abstract Bone metastasis has a significant influence on the prognosis of prostate cancer(PCa) patients. In this review, we discussed the current application of PCa bone metastasis diagnosis with single-photon emission computed tomography (SPECT) and positron emission tomography/computed tomography (...

Full description

Bibliographic Details
Main Authors: Zhao Chen, Xueqi Chen, Rongfu Wang
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Cancer Imaging
Subjects:
Online Access:https://doi.org/10.1186/s40644-022-00456-4
_version_ 1818273560350687232
author Zhao Chen
Xueqi Chen
Rongfu Wang
author_facet Zhao Chen
Xueqi Chen
Rongfu Wang
author_sort Zhao Chen
collection DOAJ
description Abstract Bone metastasis has a significant influence on the prognosis of prostate cancer(PCa) patients. In this review, we discussed the current application of PCa bone metastasis diagnosis with single-photon emission computed tomography (SPECT) and positron emission tomography/computed tomography (PET/CT) computer-aided diagnosis(CAD) systems. A literature search identified articles concentrated on PCa bone metastasis and PET/CT or SPECT CAD systems using the PubMed database. We summarized the previous studies focused on CAD systems and manual quantitative markers calculation, and the coincidence rate was acceptable. We also analyzed the quantification methods, advantages, and disadvantages of CAD systems. CAD systems can detect abnormal lesions of PCa patients’ 99mTc-MDP-SPECT, 18F-FDG-PET/CT, 18F-NaF-PET/CT, and 68 Ga-PSMA PET/CT images automated or semi-automated. CAD systems can also calculate the quantitative markers, which can quantify PCa patients’ whole-body bone metastasis tumor burden accurately and quickly and give a standardized and objective result. SPECT and PET/CT CAD systems are potential tools to monitor and quantify bone metastasis lesions of PCa patients simply and accurately, the future clinical application of CAD systems in diagnosing PCa bone metastasis lesions is necessary and feasible.
first_indexed 2024-12-12T21:59:54Z
format Article
id doaj.art-780036f1c1604fc4be6aacc200ec097d
institution Directory Open Access Journal
issn 1470-7330
language English
last_indexed 2024-12-12T21:59:54Z
publishDate 2022-04-01
publisher BMC
record_format Article
series Cancer Imaging
spelling doaj.art-780036f1c1604fc4be6aacc200ec097d2022-12-22T00:10:32ZengBMCCancer Imaging1470-73302022-04-012211710.1186/s40644-022-00456-4Application of SPECT and PET / CT with computer-aided diagnosis in bone metastasis of prostate cancer: a reviewZhao Chen0Xueqi Chen1Rongfu Wang2Department of Nuclear Medicine, Peking University First HospitalDepartment of Nuclear Medicine, Peking University First HospitalDepartment of Nuclear Medicine, Peking University First HospitalAbstract Bone metastasis has a significant influence on the prognosis of prostate cancer(PCa) patients. In this review, we discussed the current application of PCa bone metastasis diagnosis with single-photon emission computed tomography (SPECT) and positron emission tomography/computed tomography (PET/CT) computer-aided diagnosis(CAD) systems. A literature search identified articles concentrated on PCa bone metastasis and PET/CT or SPECT CAD systems using the PubMed database. We summarized the previous studies focused on CAD systems and manual quantitative markers calculation, and the coincidence rate was acceptable. We also analyzed the quantification methods, advantages, and disadvantages of CAD systems. CAD systems can detect abnormal lesions of PCa patients’ 99mTc-MDP-SPECT, 18F-FDG-PET/CT, 18F-NaF-PET/CT, and 68 Ga-PSMA PET/CT images automated or semi-automated. CAD systems can also calculate the quantitative markers, which can quantify PCa patients’ whole-body bone metastasis tumor burden accurately and quickly and give a standardized and objective result. SPECT and PET/CT CAD systems are potential tools to monitor and quantify bone metastasis lesions of PCa patients simply and accurately, the future clinical application of CAD systems in diagnosing PCa bone metastasis lesions is necessary and feasible.https://doi.org/10.1186/s40644-022-00456-4SPECTPET/CTComputer-aided diagnosisBone metastasisProstate cancer
spellingShingle Zhao Chen
Xueqi Chen
Rongfu Wang
Application of SPECT and PET / CT with computer-aided diagnosis in bone metastasis of prostate cancer: a review
Cancer Imaging
SPECT
PET/CT
Computer-aided diagnosis
Bone metastasis
Prostate cancer
title Application of SPECT and PET / CT with computer-aided diagnosis in bone metastasis of prostate cancer: a review
title_full Application of SPECT and PET / CT with computer-aided diagnosis in bone metastasis of prostate cancer: a review
title_fullStr Application of SPECT and PET / CT with computer-aided diagnosis in bone metastasis of prostate cancer: a review
title_full_unstemmed Application of SPECT and PET / CT with computer-aided diagnosis in bone metastasis of prostate cancer: a review
title_short Application of SPECT and PET / CT with computer-aided diagnosis in bone metastasis of prostate cancer: a review
title_sort application of spect and pet ct with computer aided diagnosis in bone metastasis of prostate cancer a review
topic SPECT
PET/CT
Computer-aided diagnosis
Bone metastasis
Prostate cancer
url https://doi.org/10.1186/s40644-022-00456-4
work_keys_str_mv AT zhaochen applicationofspectandpetctwithcomputeraideddiagnosisinbonemetastasisofprostatecancerareview
AT xueqichen applicationofspectandpetctwithcomputeraideddiagnosisinbonemetastasisofprostatecancerareview
AT rongfuwang applicationofspectandpetctwithcomputeraideddiagnosisinbonemetastasisofprostatecancerareview